
Antisense Therapeutics Ltd
ASX:ANP

Shareholder Yield
Current shareholder yield for ANP is
hidden
.
Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?
Peers Comparison
Shareholder Yield
Buybacks
Buyback Yield measures how much a company reduces its outstanding shares through repurchases, expressed as a percentage.
This metric directly reflects the company’s efforts to return value to shareholders. By reducing the number of shares, buybacks can increase earnings per share and potentially boost the stock's price.
Peers Comparison
Buybacks
Debt Paydown
Debt Paydown Yield measures the amount of debt a company repays within a specific period, shown as a percentage of its market capitalization.
This metric indicates how the company is using its capital to decrease financial liabilities, which can strengthen its financial health and potentially enhance shareholder value.
Peers Comparison
Debt Paydown
Price Appreciation
ANP Price
Antisense Therapeutics Ltd
Average Annual Return | 20.81% |
Standard Deviation of Annual Returns | 64.61% |
Max Drawdown | -85% |
Market Capitalization | 75.7m AUD |
Shares Outstanding | 901 545 000 |
Percentage of Shares Shorted |
N/A
|
Stock Splits
ANP's latest stock split occurred on Apr 10, 2018
The company executed a 50-for-49 stock split, meaning that for every 49 shares held, investors received 50 new shares.
Before the split, ANP traded at 0.0245 per share. Afterward, the share price was about 0.032.
The adjusted shares began trading on Apr 10, 2018. This was ANP's 4th stock split, following the previous one in Nov 6, 2013.